Society Arts & Culture: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Society Arts & Culture.

Press releases published on July 7, 2026

Jul. 7, 2026

Zapata Quantum to Present at the Global Technology Virtual Investor Conference July 9th

Indeterminate GlobeNewswire

Jul. 7, 2026

New York Times Best-Selling Author Keith Ablow Releases New Novel to Explore Radical Reinvention and Authenticity in the Age of AI

Indeterminate GlobeNewswire

Jul. 7, 2026

7-Eleven Canada Celebrates the 60th Anniversary of Slurpee® with special drops, flavours and promotions

Indeterminate GlobeNewswire

Jul. 7, 2026

Enphase Energy Announces Conference Call to Review Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 7, 2026

Engine Technology Forum Launches “Engines Power America at 250” Initiative

Indeterminate GlobeNewswire

Jul. 7, 2026

Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets Initiative) Validation for Near-Term Emissions Reduction Targets

Indeterminate GlobeNewswire

Jul. 7, 2026

Central Asia Accelerates Digital Transformation as "Digital Silk Road" Drives Development Momentum

Indeterminate GlobeNewswire

Jul. 7, 2026

Trina Solar främjar hållbar utveckling inom förnybar energi genom omfattande ESG-åtgärder

Indeterminate GlobeNewswire

Jul. 7, 2026

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

AI Takes Center Stage at Blockchain Futurist Conference 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Vitiligo, Following Encouraging Phase 1b Results

Indeterminate GlobeNewswire

Jul. 7, 2026

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

Indeterminate GlobeNewswire

Jul. 7, 2026

MariMed’s Nature’s Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

Indeterminate GlobeNewswire

Jul. 7, 2026

Solera Foundation’s WIND Movement Marks One Year of Global Impact, Spotlighting Darla Booher’s Leadership at NIADA Anniversary Celebration in Denver

Indeterminate GlobeNewswire

Jul. 7, 2026

Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement

Indeterminate GlobeNewswire

Jul. 7, 2026

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum

Indeterminate GlobeNewswire

Jul. 7, 2026

Aeluma CEO to Chair Optica Advanced Photonics Congress Industry Program on AI and Quantum

Indeterminate GlobeNewswire

Jul. 7, 2026

OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium

Indeterminate GlobeNewswire